BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3280286)

  • 1. [Anticytoplasmic antibodies as serological markers and activity parameters of Wegener's granulomatosis. A prospective study].
    Lüdemann G; Nölle B; Rautmann A; Rosenboom S; Kekow J; Gross WL
    Dtsch Med Wochenschr; 1988 Mar; 113(11):413-7. PubMed ID: 3280286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Wegener's granulomatosis and anti-cytoplasm antibodies].
    Göbel U; Briedigkeit L; Voigt B; Kettritz R; Schöntube M; Natusch R
    Z Gesamte Inn Med; 1990 Nov; 45(21):638-43. PubMed ID: 2099017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies against cytoplasmic structures of neutrophil granulocytes in Wegener's granulomatosis.
    Lüdemann G; Gross WL
    Clin Exp Immunol; 1987 Aug; 69(2):350-7. PubMed ID: 3308227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and clinical implication of anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis and rapidly progressive glomerulonephritis.
    Andrassy K; Koderisch J; Rufer M; Erb A; Waldherr R; Ritz E
    Clin Nephrol; 1989 Oct; 32(4):159-67. PubMed ID: 2572369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoantibody diagnosis in Wegener's granulomatosis].
    Lüdemann G; Lüdemann J; Nölle B; Gross WL
    Immun Infekt; 1987 Apr; 15(2):74-6. PubMed ID: 3298018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do anticytoplasmic autoantibodies (ACPA) extend our understanding of the spectrum of Wegener's granulomatosis?
    Specks U; DeRemee RA
    Pneumologie; 1990 Feb; 44 Suppl 1():424-5. PubMed ID: 2195527
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti neutrophil cytoplasm antibody in Wegener's granulomatosis].
    Yoshida M; Sakurai E; Kozaki M; Nakabayashi K; Nagasawa T
    Ryumachi; 1990 Feb; 30(1):3-9. PubMed ID: 2377939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new seromarker: an aid in the differential diagnosis of unclear scleral processes].
    Duncker G; Gross WL
    Klin Monbl Augenheilkd; 1987 Mar; 190(3):180-1. PubMed ID: 3295372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of anticytoplasmic autoantibodies in the diagnosis of Wegener's granulomatosis with subglottic stenosis.
    Gaughan RK; DeSanto LW; McDonald TJ
    Laryngoscope; 1990 Jun; 100(6):561-3. PubMed ID: 2348730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experiences with Wegener's granulomatosis from the nephrologic viewpoint].
    Zach R; Roob JM; Horn S; Kaufmann P; Winkler HM; Holzer H; Tilz GP; Pogglitsch H
    Wien Klin Wochenschr; 1991; 103(17):528-32. PubMed ID: 1949812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ACPA: the first serologic marker for Wegener's granulomatosis].
    Beigel A; Gross WL
    HNO; 1987 Sep; 35(9):390-2. PubMed ID: 3312127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to components of neutrophil cytoplasm: a new diagnostic tool in patients with Wegener's granulomatosis and systemic vasculitis.
    Parlevliet KJ; Henzen-Logmans SC; Oe PL; Bronsveld W; Balm AJ; Donker AJ
    Q J Med; 1988 Jan; 66(249):55-63. PubMed ID: 3051082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Wegener's granulomatosis: otologic and clinico-immunologic aspects].
    Kempf HG; Bootz F; Berg PA
    Laryngorhinootologie; 1992 Jan; 71(1):26-30. PubMed ID: 1543518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodiagnostic aspects of autoantibodies against myeloperoxidase.
    Ulmer M; Rautmann A; Gross WL
    Clin Nephrol; 1992 Apr; 37(4):161-8. PubMed ID: 1316247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of antineutrophil cytoplasmic antibodies for the values of Wegener's granulomatosis diagnosis and activity judgment].
    Zhang X; Jiang M; Chui J; Wang H; Ma J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):284-7. PubMed ID: 10453568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neutrophil anticytoplasmic antibodies in a patient with Wegener's granulomatosis: therapeutic implications of its detection and relation to clinical activity].
    Bosch X; Forns X; Font J; Mirapeix E; Revert L; Ingelmo M
    Med Clin (Barc); 1991 Dec; 97(20):780-2. PubMed ID: 1795572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between active Wegener's granulomatosis and anticytoplasmic antibodies.
    Tervaert JW; van der Woude FJ; Fauci AS; Ambrus JL; Velosa J; Keane WF; Meijer S; van der Giessen M; van der Hem GK; The TH
    Arch Intern Med; 1989 Nov; 149(11):2461-5. PubMed ID: 2684074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides.
    Boehme MW; Schmitt WH; Youinou P; Stremmel WR; Gross WL
    Am J Med; 1996 Oct; 101(4):387-94. PubMed ID: 8873509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticytoplasmic antibodies of polynuclears in the diagnosis and follow-up of Wegener's disease and other systemic vasculitis].
    Zenklusen C; Meyer O; Le Ti Huong Du Z; Gaudouen C; Ronco P; Mery JP; Kahn MF
    Rev Rhum Mal Osteoartic; 1990 Jan; 57(1):47-51. PubMed ID: 2181610
    [No Abstract]   [Full Text] [Related]  

  • 20. The utility of detecting of autoantibodies against neutrophil cytoplasmic components in Wegener's granulomatosis.
    Chng HH; Ganz T; Saxon A
    Ann Allergy; 1989 Nov; 63(5):411-6. PubMed ID: 2817531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.